Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Bio-Rad Laboratories, Inc.

BIO-B ✓ COMPLIANTFree checks used up today ☆ Track — members

NYSE · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Mid Cap Analyst: N/A

Last Close

$379.50

▲ +0.00%

Market Cap $9.99B · Vol 5

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

45.12

FWD: 36.65

Market Cap

$9.99B

Mid Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

94.29

Momentum

Beta

1.05

vs Market

52W High

$389.95

N/A below

52W Low

$244.54

N/A above

Volume

Avg 4

P/B

1.10

Price-to-book

ROE

N/A

Return on equity

Free Float

1.77%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Bio-Rad Laboratories, Inc. (BIO-B) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BIO-B pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.22%

+3.95%

+22.67%

+26.73%

YTD

+22.14%

+25.19%

+39.01%

-48.00%

Financials & Valuation

TTM · Annual

Total Revenue	$2.58B
Net Income	$759.90M
Revenue Growth (YoY)	-0.09%
Gross Margin	52.01%
Operating Margin	10.25%
Net Profit Margin	29.42%
ROE	N/A
ROA · ROIC	9.98% · 9.71%

P/E Ratio	45.12
Forward P/E (FY1)	36.65
PEG Ratio	0.08
P/S	3.20
P/B	1.10
P/FCF	22.07
EPS Growth	N/A
Outstanding Shares	26.74M

Technical Indicators

50-Day SMA	$366.07
200-Day SMA	$311.04
RSI (14)	94.29
Beta	1.05
52-Week High	$389.95
52-Week Low	$244.54

Volume Today	5
Avg Daily Volume (30D)	4
Relative Volume	1.25x
Volatility (10D)	19.58
Volatility (30D)	11.77
Free Float	1.77%

Analyst Consensus

N/A

Current Price $379.50

Mean Target N/A

52W Low$244.54 52W High$389.95

Current

Target

$244.54 $389.95

Current Analyst target

· 0 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S5P622

ISINUS0905721082

CountryUSA

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories +1.56% MDT Medtronic PLC -0.59% COR Cencora, Inc. +0.09% 7741.T HOYA CORPORATION -0.46% BDX Becton Dickinson and Co -0.23%

Company Profile

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.